Koers MDxHealth SA Euronext Bruxelles
Aandelen
MDXH
BE0974461940
Biotechnologie & Medisch Onderzoek
Omzet 2023 | 64,39 mln. 69,5 mln. | Omzet 2024 * | 73,13 mln. 78,93 mln. | Marktkapitalisatie | 62,04 mln. 66,96 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 | -39 mln. -42,09 mln. | Nettowinst (verlies) 2024 * | -26 mln. -28,06 mln. | EV/omzet 2023 | 1,51 x |
Nettoliquiditeiten 2023 * | - 0 | Nettoliquiditeiten 2024 * | - 0 | EV/omzet 2024 * | 0,85 x |
K/w-verhouding 2023 |
-2,37
x | K/w-verhouding 2024 * |
-2,45
x | Werknemers | 255 |
Dividendrendement 2023 * |
-
| Dividendrendement 2024 * |
-
| Vrij verhandelbaar | 97,37% |
Recentste transcriptie over MDxHealth SA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+9,16% | 45,97 mld. | |
+54,20% | 43,93 mld. | |
+11,20% | 42,34 mld. | |
-8,59% | 28,27 mld. | |
+16,40% | 27,18 mld. | |
-19,34% | 19,44 mld. | |
+13,95% | 13,83 mld. | |
+31,56% | 12,4 mld. | |
+10,63% | 11,45 mld. |